Jan 28, 2025
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.55 to $0.06.
The split itself did not change the total investment value.
MiNK Therapeutics, Inc. (INKT) trades on the NASDAQ Capital Market in the Biotechnology industry.
MiNK Therapeutics, Inc. company overviewThe latest split shown was on January 28, 2025. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
This history records one reverse split, on January 28, 2025.